Business

February 3, 2014 10:13 AM

RTP drug developer NephroGenex could go public this week

NephroGenex, a Research Triangle Park-based drug development company, is scheduled to complete an initial public offering of stock later this week.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs